INO A 152
Inselspital Bern
CH-3010 Bern
Tel. +41 31 632 59 00
pascal.juillerattest@insel.ch
Inflammatory bowel diseases:
Pascal Juillerat is privat lecturer (privat docent) and senior attending Physician of Gastroenterology at the University Hospital of Bern, Switzerland.
He first studied Biology (half-degree course) and then medicine at the universities of Neuchâtel, Basle and Lausanne, Switzerland, and obtained the Swiss Federal Diploma in Medicine in 2000. He did medical thesis on the prevalence of inflammatory bowel diseases in the Canton of Vaud. His clinical medical studies and clinical speciality training in Gastroenterology were in Lausanne and Geneva (Gastroenterologist degree 2008). Than after having passed the USMLE step 1 and step 2 CK and step 2 CS, he moved to Boston (Massachusetts, US) to develop my research and clinical skills. The first year, he pursed an epidemiologic training with the "summer Program in Clinical Effectiveness (PCE)". And achieve a Master in Epidemiology at Harvard School of Public Health (2009-2010). During the second year, he enhanced his clinical skills during an "Advanced clinical Fellowship in Inflammatory Bowel Disease" at Massachusetts General Hospital (2010-2011). In summer 2011 he decided to come back to Switzerland and work as clinician (attending physician) for general gastroenterology as well as in and outpatient care in Inflammatory bowel disease. His research in collaboration with Professor Macpherson’s lab. is mostly based on translational research projects on the microbiome and cellular markers of response to IBD therapy, as well as epidemiological project with the Swiss IBD cohort study as mentor for medical theses of the gastroenterology medical fellows. He has regular teaching activities at Bern Medical school (7 courses each year since 2012 from 3rd to 6th year of medicine), as well as his role as senior attending gastroenterologist.
2011-present
Privat lecturer (privat docent)
Senior Attending Gastroenterologist
Head of IBD in and outpatient clinical care and clinical studies
Inselspital, Bern University Hospital, Bern, Switzerland
June 2010 – July 2011
Advanced Clinical Fellow in Inflammatory Bowel Diseases, at Massachusetts General Hospital, (Profs B. Sands & J. Korzenik), Boston, United States
July 2009 – May 2010
Research fellow Medicine/ Gastrointestinal unit Massachusetts General Hospital, Boston, United States
and student at Harvard School of Public Health (Master in Science in Epidemiology)
2000-2009
Medical Fellow in Internal Medicine and Gastroenterology and Hepatology at Lausanne and Geneva University Hospital & Nyon Hospital, Switzerland
2011
Advanced Clinical Fellowship in Inflammatory Bowel Disease
Massachusetts General Hospital, Harvard Medical School, Boston, US
2010
Master degree of Science (MSc) in Epidemiology,
Harvard University, Harvard School of Public Health, Boston, US
2009 – 2010
USMLE step 2 CS
2009
Board certified (Federatio Medico Helvetica) Gastroenterologist and Hepatologist
2008
Doctor in medicine MD (Thesis Advisor: Pr. Pierre Michetti) University of Lausanne
Title: Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study
2001
USMLE step 1 and step 2 CK and step 2 CS.
2000
Physician degree (federal diploma) University of Lausanne, Switzerland
1995
half degree (Bachelor) in Biology, University of Neuchâtel, Switzerland
Human Intestinal Community Project
Goal: to combine the microbial profile data with phenotypic and genotypic information from patients from the Swiss IBD Cohort study (www.ibdcohort.ch) in order to identify possible biomarkers that may help to predict disease predisposition, activity, and responsiveness to therapy.
Epidemiology of IBD patients with
A) Alcohol consumption, B) Cannabis consumption and C) Smoking . (As mentor, PI for medical thesis of 3 fellows)
A prospective, countrywide cohort based, running since November 2006, was developed thanks to the collaboration of a national network of clinical University centers, private practice specialists, pathologists and epidemiologists.
SENSITIVITY to ANTI-TNFS INHIBITION IN CROHN’S DISEASE AND ULCERATIVE COLITIS: The SATICC- Study
Prospective (2 years) validation of a new diagnostic tool (ImmunoAssay) to assess functional TNF blockade in order to optimize the decision-making process in case of loss of response to anti-TNF agents.
2015-2016
Human Intestinal Community Project : Grant from Inselspital
Principal investigator : A. Macpherson
Sub - investigator : P. Juillerat
Goal: to combine the microbial profile data with phenotypic and genotypic information from patients from the Swiss IBD Cohort study (www.ibdcohort.ch) in order to identify possible biomarkers that may help to predict disease predisposition, activity, and responsiveness to therapy.
2012 - 2015
SENSITIVITY to ANTI-TNFS INHIBITION IN CROHN’S DISEASE AND ULCERATIVE COLITIS : The SATICC- Study
Principal investigator Grant from Ruth & Arthur Scherbarth Foundation
2009-2012
Comparison between Swiss and American Cohort Studies of Inflammatory Bowel Diseases Patients
Starting 07.2009 – 07.2011 Principal investigator Swiss National Science Foundation 1 year + 6 months renewal (Grant n°: PBLAP3—124341, P. Juillerat, MD).
2010 – 2011
Proton-pump Inhibitors in Inflammatory Bowel Disease
Grant from The Foundation for Clinical Research in IBD (www.myIBD.org) Principal investigator : Pascal Juillerat